- Home
- SLGL
as 07-08-2024 4:00pm EST
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline consists of silica-based microencapsulation technology platform, and several generic product candidates across multiple indications.
| Founded: | 1997 | Country: | Israel |
| Employees: | N/A | City: | N/A |
| Market Cap: | 22.3M | IPO Year: | 2018 |
| Target Price: | $6.50 | AVG Volume (30 days): | 31.0K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.83 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.63 - $4.05 | Next Earning Date: | 08-08-2024 |
| Revenue: | $1,720,000 | Revenue Growth: | -58.84% |
| Revenue Growth (this year): | 119.82% | Revenue Growth (next year): | 131.09% |
Latest Sol-Gel Technologies Ltd. News
SLGL Breaking Stock News: Dive into SLGL Ticker-Specific Updates for Smart Investing
Simply Wall St.
a month ago
We're A Little Worried About Sol-Gel Technologies' (NASDAQ:SLGL) Cash Burn Rate
MT Newswires
a month ago
Sol-Gel Technologies Gets Noncompliance Notice From Nasdaq
GlobeNewswire
a month ago
Sol-Gel Announces Receipt of Nasdaq Minimum Price Notice
Zacks
2 months ago
Sol-Gel Technologies Ltd. (SLGL) Reports Q1 Loss, Lags Revenue Estimates
GlobeNewswire
2 months ago
Sol-Gel Reports First Quarter 2024 Financial Results and Provides Corporate Updates
GlobeNewswire
2 months ago
Sol-Gel and Beimei Pharma Announce an Asset Purchase Agreement to Commercialize TWYNEO® in the Mainland of China, Hong Kong, Macau, Taiwan and Israel
GlobeNewswire
3 months ago
Sol-Gel’s Collaboration Partner First-to-File ANDA Drug Product Generic to Zoryve® Cream
Simply Wall St.
4 months ago
Sol-Gel Technologies Full Year 2023 Earnings: Revenues Beat Expectations, EPS In Line
Share on Social Networks:
Disclaimer
The information presented on this page, "SLGL Sol-Gel Technologies Ltd. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.